Akihiro Eguchi

Akihiro Eguchi

Forsker


Publication year:
All
  1. 2022
  2. Published

    Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance

    Emdal, Kristina Bennet, Palacio-Escat, N., Wigerup, C., Eguchi, Akihiro, Nilsson, H., Bekker-Jensen, D. B., Rönnstrand, L., Kazi, J. U., Puissant, A., Itzykson, R., Saez-Rodriguez, J., Masson, K., Blume-Jensen, P. & Olsen, Jesper Velgaard, 2022, In: Cell Reports. 40, 6, 25 p., 111177.

    Research output: Contribution to journalJournal articlepeer-review

ID: 259144034